Citation only
via Europe PMC
Molecular targets for the treatment of sarcopenia: a geroscience approach.
Picca A, Calvani R, Coelho-Júnior HJ, Cacciatore S, Zeidan RS, Tosato M, Landi F, Marzetti E.
Expert opinion on therapeutic targets · 2026
Abstract
<h4>Introduction</h4>Sarcopenia is increasingly recognized as a multisystem geroscience condition. The limited efficacy of first-generation anabolic therapies has challenged the paradigm that increasing muscle mass is sufficient to restore physical performance, highlighting the need for therapeutic strategies that address the biological complexity of muscle aging.<h4>Areas covered</h4>This review examines the evolution of molecular targets for sarcopenia, from anabolic pathways to emerging geroscience-based targets. We discuss mechanistic and clinical evidence supporting these approaches, emphasizing the distinction between molecular target engagement and functional efficacy, and examine how biological context, patient stratification, and multicomponent interventions influence therapeutic outcomes. The literature was identified through a comprehensive PubMed search, with emphasis on mechanistic studies, clinical trials, and recent advances in geroscience.<h4>Expert opinion</h4>The future of therapeutics against sarcopenia will likely depend less on identifying anabolic agents than on matching molecular targets to the dominant biological mechanisms limiting muscle function in individual patients. Biomarkers of target engagement, deep phenotyping, and mechanism-informed combination strategies integrating pharmacological, nutritional, and exercise interventions will be essential to improve patient stratification and translate molecular target modulation into meaningful functional benefit.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1080/14728222.2026.2761684
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
A, P., R, C., HJ, C., S, C., RS, Z., M, T., F, L., & E., M. (2026). Molecular targets for the treatment of sarcopenia: a geroscience approach. <em>Expert opinion on therapeutic targets</em>. https://doi.org/10.1080/14728222.2026.2761684
Vancouver
A P, R C, HJ C, S C, RS Z, M T, et al. Molecular targets for the treatment of sarcopenia: a geroscience approach. Expert opinion on therapeutic targets. 2026. doi:10.1080/14728222.2026.2761684.
BibTeX
@article{picca2026Molecu,
title = {Molecular targets for the treatment of sarcopenia: a geroscience approach.},
author = {Picca A and Calvani R and Coelho-Júnior HJ and Cacciatore S and Zeidan RS and Tosato M and Landi F and Marzetti E.},
journal = {Expert opinion on therapeutic targets},
year = {2026},
doi = {10.1080/14728222.2026.2761684},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of veterinary science 2025
Open access · OA
Geroscience and aging interventions in dogs and cats: from mechanisms to clinical care
Elsevier eBooks 2016
Citation only
The Aging Muscle and Sarcopenia
Elsevier eBooks 2019
Citation only
Aging Muscle and Sarcopenia
Pharmaceuticals (Basel, Switzerland) 2026
Citation only
Phytochemical-Based Therapeutic Strategies for Sarcopenia: From Molecular Mechanisms to Clinical Translation.
Precision medication. 2025
Open access · CC-BY
Molecular aspects of metformin’s anti-aging properties for muscle function and longevity in Drosophila melanogaster
Journal of Veterinary Science 2025
Open access · CC-BY